Literature DB >> 2227449

Chloramphenicol resistance in Campylobacter coli: nucleotide sequence, expression, and cloning vector construction.

Y Wang1, D E Taylor.   

Abstract

A chloramphenicol-resistance determinant (CmR), originally cloned from Campylobacter coli plasmid pNR9589 in Japan, was isolated and the nucleotide sequence determined, which contained an open reading frame of 621 bp. The gene product was identified as Cm acetyltransferase (CAT), which had a putative amino acid sequence that showed 43% to 57% identity with other CAT proteins of both Gram+ and Gram- origin. Although expression of the cat gene was constitutive in both C. coli and Escherichia coli, results of primer extension experiments indicated that transcription was initiated at different sites in these two species. A kanamycin-resistance determinant, identified as the aphA-3 gene, was located downstream from the cat gene. The codon usage of the cat gene is very different from that used in E. coli, however, the CAT polypeptide was synthesized in large amounts in E. coli maxicells. Therefore, the codon usage bias is not one of the obstacles which affects Campylobacter spp. gene expression in E. coli. New Campylobacter cloning vectors were constructed in this study.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2227449     DOI: 10.1016/0378-1119(90)90463-2

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  132 in total

1.  Essential thioredoxin-dependent peroxiredoxin system from Helicobacter pylori: genetic and kinetic characterization.

Authors:  L M Baker; A Raudonikiene; P S Hoffman; L B Poole
Journal:  J Bacteriol       Date:  2001-03       Impact factor: 3.490

2.  Critical role of LuxS in the virulence of Campylobacter jejuni in a guinea pig model of abortion.

Authors:  Paul Plummer; Orhan Sahin; Eric Burrough; Rachel Sippy; Kathy Mou; Jessica Rabenold; Mike Yaeger; Qijing Zhang
Journal:  Infect Immun       Date:  2011-12-05       Impact factor: 3.441

3.  Prevalence, development, and molecular mechanisms of bacteriocin resistance in Campylobacter.

Authors:  Ky Van Hoang; Norman J Stern; Arnold M Saxton; Fuzhou Xu; Ximin Zeng; Jun Lin
Journal:  Appl Environ Microbiol       Date:  2011-01-28       Impact factor: 4.792

4.  Detection on surfaces and in Caco-2 cells of Campylobacter jejuni cells transformed with new gfp, yfp, and cfp marker plasmids.

Authors:  W G Miller; A H Bates; S T Horn; M T Brandl; M R Wachtel; R E Mandrell
Journal:  Appl Environ Microbiol       Date:  2000-12       Impact factor: 4.792

5.  Global transposon mutagenesis and essential gene analysis of Helicobacter pylori.

Authors:  Nina R Salama; Benjamin Shepherd; Stanley Falkow
Journal:  J Bacteriol       Date:  2004-12       Impact factor: 3.490

6.  In vivo recognition of the fecA3 target promoter by Helicobacter pylori NikR.

Authors:  Simona Romagnoli; Francesca Agriesti; Vincenzo Scarlato
Journal:  J Bacteriol       Date:  2011-01-07       Impact factor: 3.490

7.  A convenient and robust in vivo reporter system to monitor gene expression in the human pathogen Helicobacter pylori.

Authors:  Andrea Vannini; Francesca Agriesti; Flaviana Mosca; Davide Roncarati; Vincenzo Scarlato; Alberto Danielli
Journal:  Appl Environ Microbiol       Date:  2012-07-06       Impact factor: 4.792

8.  Helicobacter hepaticus hydrogenase mutants are deficient in hydrogen-supported amino acid uptake and in causing liver lesions in A/J mice.

Authors:  Nalini S Mehta; Stephane Benoit; Jagannatha V Mysore; Renato S Sousa; Robert J Maier
Journal:  Infect Immun       Date:  2005-09       Impact factor: 3.441

9.  Phosphorylation-independent activity of atypical response regulators of Helicobacter pylori.

Authors:  Jennifer Schär; Albert Sickmann; Dagmar Beier
Journal:  J Bacteriol       Date:  2005-05       Impact factor: 3.490

10.  L-serine catabolism via an oxygen-labile L-serine dehydratase is essential for colonization of the avian gut by Campylobacter jejuni.

Authors:  Jyoti Velayudhan; Michael A Jones; Paul A Barrow; David J Kelly
Journal:  Infect Immun       Date:  2004-01       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.